Triallogix offers a platform that lets patients discover active clinical studies and easily enroll to help advance medical science. In addition to participant matching, the company provides regulatory and trial‑management expertise to sponsors, ensuring studies run compliantly and efficiently. By streamlining recruitment and offering end‑to‑end trial support, Triallogix aims to accelerate the delivery of new therapies.
Funding
Funding not disclosed
Founders
Product
Problem
Patients and volunteers often lack a centralized way to find active clinical research studies that match their health profile, leading to missed enrollment opportunities. Sponsors and research sites also face complex regulatory documentation and trial management tasks that can cause delays and compliance risks.
Solution
TrialLogix offers an online portal where individuals can browse and enroll in currently recruiting medical studies, streamlining participant recruitment. In parallel, the platform provides regulatory and trial management services that prepare, review, and maintain required documentation to keep studies compliant. By integrating participant enrollment with back‑office compliance support, TrialLogix reduces recruitment friction and helps sponsors avoid regulatory setbacks, accelerating study start‑up and execution.
Target Audience
Primary users are prospective clinical trial participants seeking enrollment opportunities, and pharmaceutical sponsors or CROs that need regulatory and trial management assistance.
Features
- searchable database of active clinical trials with filters for condition, location, and eligibility criteria
- online enrollment workflow that captures consent and participant information securely
- end‑to‑end regulatory document preparation, including INDs, IRB submissions, and safety reporting
- customizable consulting packages ranging from full‑stack trial management to à la carte regulatory support
- compliance monitoring tools that track document status, deadlines, and audit trails
- secure data handling with encryption and role‑based access controls